← All Sponsors
SPONSOR

Shanghai Hengrui Pharmaceutical Co., Ltd.

Total Trials
5
Recruiting
5
Phases
Phase 1, Phase 1, Phase 2, Phase 2
Conditions studied: PainSolid TumorAdvanced Gynecological MalignancyAlzheimer's DiseaseCLDN18.2-positive Advanced Solid Tumor
NCT07301333 Phase 1
Recruiting

A Study of Single and Multiple Doses of HRS-6257 in Healthy Subjects

Pain
China View Trial →
NCT07229586 Phase 1, Phase 2
Recruiting

A Study of SHR-7367 With Anti-tumor Agents in Patients With Solid Tumors

Solid Tumor
China View Trial →
NCT06654440 Phase 2
Recruiting

A Trial of SHR-A2102 for Treatment of Advanced Gynecological Malignancy

Advanced Gynecological Malignancy
China View Trial →
NCT06199037 Phase 2
Recruiting

Safety and Pharmacodynamics of SHR-1707 in Alzheimer's Disease Patients

Alzheimer's Disease
China View Trial →
NCT06350006 Phase 1
Recruiting

SHR-A1904 Combinations in CLDN18.2-Positive Advanced Solid Tumor

CLDN18.2-positive Advanced Solid Tumor
China View Trial →